Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis. Meng G, Liu X, Ma T, Lv D, et al. PLoS One 2022;17:e0263629.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meng G, Liu X, Ma T, Lv D, et al. Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis. PLoS One 2022;17:e0263629.
PMID: 35113949